Use of medicinal plants by indigenous people as a possible source of drugs for Covid-19
DOI:
https://doi.org/10.37431/conectividad.v3i2.37Keywords:
COVID-19, Medicinal plants, IndigenousAbstract
The World Health Organization (WHO) on March 11, 2020 declares the pandemic for the disease COVID-19, this was caused by a coronavirus, the SAR-CoV-2. By the end of 2021, many indigenous peoples reported a decrease in the number of people contaminated and deaths from COVID-19, pointing to the application of medicinal plants as the main cause of this improvement. The objective was to validate the use of medicinal plants of indigenous peoples, to combat COVID-19. The methodology used was documentary research. It turned out that medicinal plants have been a source of drugs for different diseases; It is estimated that 85% of the planet's population uses medicinal plants as the main source of medical care, and more than 40% of synthetic drugs in pharmaceutical markets are derived from plants and natural products. It was concluded that science is based on this ancestral knowledge and that also the extracts of the different herbal products and the molecules that exert an anti-SARSCOV-1 action, inhibit the virus directly from its entry by blocking the ACE-2 receptors, proteins that are also used by SARS-COV-2. Studies using these molecules may be promising therapeutic treatment against COVID-19.
References
Adhikari B, Marasini BP, R. B. (2021). Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19. Phytother Res., 1298-1312. https://doi.org/10.1002/ptr.6893
Ahmad SR. (2021). Medicinal Plants--Derived Natural Products and Phytochemical Extract as Potential Therapies for Coronavirus: Future Perspective. Biomedical and Pharmacology Journal., 771-792. https://doi.org/10.13005/bpj/2181
Benarba Bachir, P. A. (2020). Plantas Medicinales como Fuentes de Moléculas Activas Contra el COVID-19. Frontiers En Farmacología, 1189.
Boozari M, H. H. (2021). Natural products for COVID‐19 prevention and treatment regarding to previous coronavirus infections and novel studies. Phytotherapy Research, 864-876. https://doi.org/10.1002/ptr.6873
Deguchi A. (2015). Curcumin targets in inflammation and cancer. Endocr. Metab. Immune Disord. Drug Targets, 96. https://doi.org/10.2174/1871530315666150316120458
Lin SC, Ho CT, Chuo WH, Li S, Wang TT, L. C. (2017). Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect Dis, 144. https://doi.org/10.1186/s12879-017-2253-8
Lozada-Requena, I., Núñez Ponce, C., Lozada-Requena, I., & Núñez Ponce, C. (2020). COVID-19: respuesta inmune y perspectivas terapéuticas. Revista Peruana de Medicina Experimental y Salud Pública, 37(2), 312-319. https://doi.org/10.17843/rpmesp.2020.372.5490
Mahoney, M., Damalanka, V. C., Tartell, M. A., Chung, D. hee, Lourenço, A. L., Pwee, D., Mayer Bridwell, A. E., Hoffmann, M., Voss, J., Karmakar, P., Azouz, N. P., Klingler,
A. M., Rothlauf, P. W., Thompson, C. E., Lee, M., Klampfer, L., Stallings, C. L., Rothenberg, M. E., Pohlmann, S., … Janetka, J. W. (2021). A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells. Proceedings of the National Academy of Sciences of the United States of America, 118(43). https://doi.org/10.1073/pnas.2108728118
Minchala Rosa Ramirez Andres, Aguayza Maya, torres Larry, Romero Lilia, pogyo Gloria,S. mercedes. (2020). La medicina Herbaria como prevención y tratamiento frente al COVID-19No Title. AVFT Archivos Venezolanos de Farmacología y Terapéutica, 949- 952.
Montaño, L. M., Flores-Soto, E., Montaño, L. M., & Flores-Soto, E. (2020). COVID-19 y su asociación con los inhibidores de la enzima convertidora de angiotensina y los antagonistas de los receptores para angiotensina II. Revista de La Facultad de Medicina, 63(4), 30-34.
https://doi.org/10.22201/fm.24484865e.2020.63.4.05
Nassiri‐Asl M, H. H. (2020). Revisión de los efectos farmacológicos de Vitis vinifera (Uva) y sus compuestos bioactivosNo Title. Phytother Re, 1197.
OMS. (2009). Promoción y desarrollo de la medicina tradicional. Consejo Ejecutivo de Medicina Tradicional 124 a Reunión. Ginebra/Alma Ata URSS:
PS, M. (2006). The molecular biology of coronaviruses. Adv Virus Res, 66, 193-292. https://doi.org/10.1016/S0065-3527(06)66005-3
Shailendra K. Saxena. (2019). Enfermedad por coronavirus 2019 (COVID-19) Epidemiología, Patogénesis, Diagnóstico y Terapéutica.
Sunkel oswaldo, Bárcena Alicia, Cimoli mario, G. R. (2020). El COVID-19 y la crisis socioeconómica en América Latina y el Caribe. Revista Cepal, 132(edición especial), 141.
TY, Ho, Wu SL, Chen JC, Li CC, H. C. (2007). Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antiviral Res, 92-101. https://doi.org/10.1016/j.antiviral.2006.04.014
Wang D, Hu B, Hu C, Zhu F, X. Y. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 1061-1069. https://doi.org/10.1001/jama.2020.1585
Yun B, Lee I, Kim J, Chung S, Shim G, Y. I. (2000). Lipid peroxidation inhibitory activity of some constituents isolated from the stem bark of Eucalyptus globulus. Archives of Pharmacal Research, 147. https://doi.org/10.1007/BF02975503
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Instituto Superior Tecnológico Universitario Rumiñahui
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The originals published in the electronic edition under the first publication rights of the journal belong to the Instituto Superior Tecnológico Universitario Rumiñahui; therefore, it is necessary to cite the source in any partial or total reproduction. All the contents of the electronic journal are distributed under a Creative Commons Attribution-Noncommercial 4.0 International (CC-BY-NC 4.0) license.
2.png){kind=logo}
